Search clinical trials for: subcutaneous infusion

Total 7146 results

University Hospital, Caen

Completed

Switch From U-100 Insulin Analog to U-500 Regular Insulin in Pumps for Type 2 Diabetes

Type 2 Diabetes Mellitus
Arecor Limited

Completed

AT247, NovoLog® and Fiasp® Administered Via Continuous Subcutaneous Infusion in Glucose Clamp Study

Diabetes Mellitus, Type 1

United States
Capillary Biomedical, Inc.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Integrated... and other collaborators

Completed

Pharmacokinetics (PK)/ Pharmacodynamics (PD) of an Extended Wear Infusion Set for Continuous Subcutaneous Insulin Infusion (CSII) in Type 1 Diabetes Mellitus (T1DM) Patients ("PEXIS")

Diabetes Mellitus, Type 1 | Type 1 Diabetes

United States
Federico II University

Terminated

Individualized, Technological Interventions for Diabetes Care in the COVID-19 Ward (Initiator)

Diabetes Mellitus | Covid19

Italy
Takeda

Completed

Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)

Crohn's Disease

Belgium, Israel, Korea, Republic of, Netherlands, Australia, Denmark, Russian Federation, Hungary, Serbia, Bulgaria, Canada, Germany, Italy, Poland, Slovakia, Czechia, Mexico, Romania, Brazil, Estonia, United States, Bosnia and Herzegovina and more
Sanofi

Completed

Safety Assessment of SAR341402 and NovoLog® Used in Continuous Subcutaneous Insulin Infusion for Type 1 Diabetes Mellitus Patients

Type 1 Diabetes Mellitus

United States
University of Maryland, Baltimore

Completed

Early Subcutaneous Insulin Glargine Plus Standard of Care for Treatment of Diabetic Ketoacidosis

Diabetic Ketoacidosis

United States
Kinderkrankenhaus auf der Bult

Completed

Study on the Use of the Insulin Pump Tandem X:2 With Control IQ Algorithm - Update (UNIQUE)

Type 1 Diabetes | Insulin Therapy

Germany
Ypsomed AG
Diabetes Center Berne Research AG

Completed

YpsoPump Occlusion Detection Algorithm: Collection of Real-world Data for In-silico Evaluation of a New Software Algorithm to Refine Occlusion Detection in Subjects With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion

Diabetes Mellitus, Type 1

Germany, Switzerland
Castilla-La Mancha Health Service
Spanish Diabetes Association

Completed

Clinical Efficacy of Insulin Pumps in Type 1 Diabetes Mellitus Patients in Spain

Type 1 Diabetes

Spain
National Institute of Allergy and Infectious Diseases...
Biogen

Completed

An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive

HIV Infections

United States
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Effect of Canagliflozin in T1DM (Type 1 Diabetes Melitus) After Interruption of Continuous Subcutaneous Insulin Infusion

Type 1 Diabetes

United States
SQ Innovation, Inc.
Accel Clinical Services

Completed

Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure

Heart Failure

United States
UCB Biopharma S.P.R.L.

Completed

A Study to Evaluate Safety and Tolerability of Single Ascending Doses of Rozanolixizumab Administered by Subcutaneous Infusion in Healthy Japanese, Chinese and Caucasian Study Participants

Healthy-volunteers

United Kingdom
Clinique Saint Pierre Ottignies

Completed

Intravenous Versus Subcutaneous Administration of Low Molecular Weight Heparin for Thromboprophylaxis in Critically Ill Patients

Critical Illness
Baxalta now part of Shire

Completed

Phase 2/3 Study of IGSC, 20% in PIDD

Primary Immunodeficiency Diseases (PID)

United States, Canada
Baxalta now part of Shire

Completed

GLASSIA Infusion Rate Study

Healthy Volunteers | Alpha1-antitrypsin Deficiency

United States
Pfizer

Terminated

Efficacy And Safety Study Of Tanezumab Subcutaneous Administration In Osteoarthritis - A Subcutaneous/Intravenous Bridging Study

Pain | Arthritis | Osteoarthritis

United States
AstraZeneca

Completed

A Study of MEDI7352 in Painful Osteoarthritis of the Knee

Chronic Pain

Germany, Sweden, United Kingdom
argenx

Completed

A Phase 1 Study to Compare the Safety and Effect of Efgartigimod as an Intravenous Infusion With the Effect of Efgartigimod as a Subcutaneous Injection in Healthy Volunteers

Healthy Volunteers

Netherlands
Mountain Diabetes and Endocrine Center
Novo Nordisk A/S

Completed

Basal Insulin Glycemic ControL With DEglugec vs Aspart Via Pump (BIG LEAP)

Type1 Diabetes Mellitus

United States
Jun Wang

Completed

the Effect of Different Drugs and Infusion Ways on Degree of Postoperative Comfort

Analgesia, Patient-Controlled

China
Steno Diabetes Center Copenhagen
Nordsjaellands Hospital

Completed

Steno Tech Explore: A Study of Insulin Pump Users With Type 1 Diabetes

Diabetes Mellitus, Type 1

Denmark
Sheffield Teaching Hospitals NHS Foundation Trust
King's College Hospital NHS Trust; Cambridge University Hospitals NHS Foundation... and other collaborators

Completed

The REPOSE (Relative Effectiveness of Pumps Over MDI and Structured Education) Trial (REPOSE)

Type 1 Diabetes

United Kingdom
Tulane University Health Sciences Center

Completed

Comparison of Insulins Aspart and Lispro in Insulin Pumps

Type 1 Diabetes Mellitus

United States
Mountain Diabetes and Endocrine Center

Unknown

The Efficacy and Safety of Faster Insulin Aspart (Fiasp®) Compared to Conventional Insulin Aspart (NovoLog®) as Correction Bolus (PLATEAU)

Type 1 Diabetes Mellitus

United States
Impatients N.V. trading as myTomorrows
Kamada, Ltd.

No longer available

Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)

Alpha 1-Antitrypsin Deficiency | Graft Vs Host Disease | Graft-versus-host-disease | Acute-graft-versus-host Disease | Steroid Refractory Acute Graft Versus Host Disease | Alpha-1 Proteinase Inhibitor | Alpha-1 Protease Inhibitor Deficiency | Acute Graft-Versus-Host Reaction Following Bone Marrow...
Texas Diabetes & Endocrinology, P.A.

Completed

FIasp® vs. Novolog® in Type 1 Diabetics Using 670G Medtronic Pump

Type 1 Diabetes Mellitus

United States
Celularity Incorporated

Terminated

A Safety Study of Human Cord Blood Derived, Culture Expanded Natural Killer Cell (PNK-007) Infusion With Subcutaneous Recombinant Human IL-2 (rhIL-2) in Adults With Relapsed and/or Refractory Acute Myeloid Leukemia (AML)

Leukemia, Myeloid, Acute

United States
Celularity Incorporated

Completed

A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)

Multiple Myeloma

United States
scPharmaceuticals, Inc.
CSSi Life Sciences; Clinical Trial Data Services, Inc.

Completed

An Open Label Study to Evaluate the Impact of Duration of Subcutaneous Infusion of a Novel, pH Neutral Formulation of Furosemide (Furoscix®) on Safety and Local Skin Tolerability

Healthy

United States
Saint-Joseph University

Completed

Evaluation of Efficacy and Safety of Subcutaneous Acetaminophen (APAPSubQ)

Pain | Fever | Drug Effect | Drug Reaction

Lebanon
Groupe Hospitalier Pitie-Salpetriere

Completed

Flash Glucose Measure System and Continuous Subcutaneous Insulin Infusion Therapy in Poorly Controlled Diabetes Type 1 Patients (FREESTYLE)

Diabetes Mellitus, Type 1 | Glucose Metabolism Disorders (Including Diabetes Mellitus)

France
Abramson Cancer Center of the University of Pennsylvania

Completed

IFN-DLI for Relapsed Acute Leukemia After Allo-SCT

Leukemia

United States
University of Padova

Completed

Continuos Subcutaneous Insulin Infusion in Italy (IMITA2)

Type 1 Diabetes

Italy
Imperial College London

Completed

Flat and Circadian Insulin Infusion Rates in Continuous Subcutaneous Insulin Infusion (FIRST1D)

Type 1 Diabetes

United Kingdom
Jewish General Hospital

Withdrawn

Hypotonic Treprostinil Subcutaneous Infusion for Control of Treprostinil Related Site Pain

Pulmonary Arterial Hypertension

Canada
Medtronic Diabetes
Medtronic Poland Spółka z ograniczoną odpowiedzialnością

Completed

Orchestra Pregnancy Observational Study in Poland

Pregnancy | Type 1 Diabetes Mellitus

Poland
Castilla-La Mancha Health Service
Universidad de Córdoba; University of Castilla-La Mancha

Completed

Continuous Subcutaneous Insulin Infusion Versus Multiple Dose Insulin Injections in Routine Clinical Practice (real-ECIMI)

Type 1 Diabetes Mellitus

Spain
Xeris Pharmaceuticals
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism

Congenital Hyperinsulinism

United States
NeuroDerm Ltd.

Withdrawn

A Clinical Study Investigating the Efficacy, Tolerability, and Safety of Continuous Subcutaneous ND0612 Infusion Given as Adjunct Treatment to Oral Levodopa in Patients With Parkinson's Disease With Motor Fluctuations

Parkinson's Disease

Israel
Novo Nordisk A/S

Completed

Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes (Onset® 5)

Diabetes | Diabetes Mellitus, Type 1

United States, Russian Federation, United Kingdom, Canada, France, Netherlands, Belgium, Germany, Slovenia
AbbVie

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Infusions of ABBV-951 in Subjects With Parkinson's Disease

Parkinson's Disease (PD)

United States
J.H. DeVries
Rijnstate Hospital; Inreda Diabetic B.V.

Completed

Algorithm to Control Postprandial, Post Exercise and Night Glucose Excursions in a Portable Closed Loop Format, (APPEL5)

Diabetes Mellitus, Type 1

Netherlands
Peking Union Medical College Hospital

Unknown

Preliminary Exploration on the Operational Standards of Insulin Pump Installation in Diabetes Clinic in China

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative Period

China
Nanjing First Hospital, Nanjing Medical University

Unknown

Therapeutic Effect of Dapagliflozin Combined With CSII on Newly Diagnosed Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus
Eli Lilly and Company

Completed

A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes (PRONTO-Pump)

Diabetes Type 1

United States, Spain
BriovaRx Infusion Services

Terminated

Gamma Globulin Observations and Outcomes Database for Patients With Primary Immunodeficiency Disease (GOOD-SHEPARD-PI)

Primary Immune Deficiency Disorder

United States
Britannia Pharmaceuticals Ltd.

Completed

Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson's Disease (TOLEDO)

Parkinson's Disease

Spain, United Kingdom, Netherlands, Austria, Denmark, France, Germany
Beijing Hospital

Unknown

Comparing the Efficacy and Safety Between Short-term Continuous Subcutaneous Beinaglutide Injection and Continuous Subcutaneous Insulin Infusion (CSII) for Newly Diagnosed Type 2 Diabetes

Type 2 Diabetic Patients

China

3

Subscribe